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sented his early results from the IDE clinical trial on PMEGs in
a series of 26 patients with juxtarenal aortic aneurysms. He is to
be congratulated in achieving excellent early outcomes with
limited tools on the back table.
In a custom-made device, it is possible to place the fenestra-
tions in the optimum position to match the patient’s anatomy
and adjust the stents to ﬁt around them, but when fenestrations
are made on an already-sterile graft, it may be necessary to place
the fenestrations in a perhaps less-than-optimum position to ﬁt
in between the stent struts. The fact that Dr Starnes can achieve
a 100% technical success rate is testimony to his planning skills
and technical expertise.
Devices modiﬁed in this manner were by all accounts similar
to the early fenestrated grafts that were made and implanted in
other patients outside the United States. Although the follow-up
period of this present series is a mere 11 months, there is no
reason to suspect that longer-term outcomes would not be as
good, if not better, than those published by the same group in
this month’s Journal of Vascular Surgery. In the inevitable
comparison between the two series, it is evident that a larger
number of fenestrations were used in the later IDE trial, in partic-
ular for the SMA. The authors attributed this to a need to
maximize proximal seal.
I have the following questions for Ben:
You addressed the issue of not stenting the SMA due to limi-
tations of the stent struts crossing the large fenestration. In this
manner, the SMA fenestration essentially functions as a large
scallop and cannot add much to extending the proximal seal.
In your opinion, would that limit the PMEGs to treating juxtare-
nal aneurysms, but not true suprarenal aneurysms? Have you
used this graft to treat aneurysms with less than the 2-mm
neck length?
On a technical note, when you used nitinol snares around the
fenestrations, do these function only as a radiopaque marker? In
standard fenestrated grafts, the nitinol reinforcing rings help to
lock the stents onto the fenestration and allow for better ﬂaring.
Unreinforced fenestrations may stretch and expand in size to the
diameter of virtually any balloon that was used, and the origin ofthe target vessel could be expanded to more than would be consid-
ered safe. Do you see these as concerns for long-term failure?
Finally, in light of the competing fenestrated systems such as
the Ventana and the Anaconda, or the newer-generation Zenith
p-branch off-the-shelf devices, how do you see the role of physi-
cian-modiﬁed grafts in the future?
I thank the society for the opportunity to discuss this paper.
Dr Benjamin Ware Starnes. Thank you, Stephen, for those
insightful comments. Regarding the SMA fenestration remaining
unstented, I do not believe that this fenestration serves merely as
a scallop. In fact, with PMEG, I have found that the creation of
a scallop using these techniques actually disrupts the integrity of
the proximal graft fabric and makes the device more difﬁcult to
reload into the sheath. Also, there is actually quite good seal in
and around the unstented SMA fenestration in these cases.
Remember that we are conﬁned by the standard Cook device
design and try at all costs to leave the renal fenestrations strut-
free. This then, in the majority of situations, leaves struts spanning
the SMA fenestration. Stenting the SMA in this situation, I believe
is fraught with hazard to include stent kinking and crushing with
greater radial strength of the existing struts over the renal stents.
This leads to the second part of your ﬁrst question which isd
PMEG is really only for true juxtarenal aneurysms with at least 2
mm of neck below the renal arteries, not for para- or suprarenal
aneurysms. All of these patients had at least 2 mm of neck with
a range of between 2 and 11 mm.
The gold markers are hand sewn into place using 4-0 prolene
in a 720 circumferential fashion, so while not being a true rein-
forced fenestration, with good aortic wall apposition and parallel
walls, I believe this is a durable alternative. One of the beneﬁts
of this IDE is going to be the ability to assess the durability of
this approach over the long term.
Finally, even with off-the-shelf solutions in the industrial pipe-
line, I still believe that there will be a role for PMEG in speciﬁc
anatomic situations. These grafts are truly customized to each
and every patient, and time will tell if they are even more durable
than an off-the-shelf solution to manage more than just 70% of
patients with juxtarenal aortic aneurysms, which is what these
new grafts tout.
